Cargando…

lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma

The mechanism of RP11-838N2.3 promoting cisplatin resistance in lung adenocarcinoma (LAD) was unclear. The RP11-838N2.3 expression level in cells and LAD tissues was detected by qPCR. We constructed lentivirus-mediated GV303 overexpression and GV248 shRNA vector targeting RP11-838N2.3, then infected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jie, Jiang, Feng, Hu, Lijuan, Zhang, Fan, Wang, Junjun, Huang, Kate, Wang, Yumin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312708/ https://www.ncbi.nlm.nih.gov/pubmed/32626737 http://dx.doi.org/10.1155/2020/2806042

Ejemplares similares

Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2018)

Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2022)

LncRNA LINC01512 Promotes the Progression and Enhances Oncogenic Ability of Lung Adenocarcinoma
por: Chen, Jie, et al.
Publicado: (2017)

Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma
por: Fu, Jiali, et al.
Publicado: (2021)

lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma
por: Wang, Yumin, et al.
Publicado: (2018)

Analysis of lncRNA UCA1‐related downstream pathways and molecules of cisplatin resistance in lung adenocarcinoma
por: Zhou, Huixin, et al.
Publicado: (2020)

Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma
por: Hu, Lijuan, et al.
Publicado: (2017)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2020)

LncRNA RP11-248E9.5 and RP11-456D7.1 are Valuable for the Diagnosis of Childhood Pneumonia
por: Chen, Xiudong, et al.
Publicado: (2021)

Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines
por: Liu, Yanting, et al.
Publicado: (2016)

LncRNA RP11-138J23.1 Contributes to Gastric Cancer Progression by Interacting With RNA-Binding Protein HuR
por: Xu, Yongcan, et al.
Publicado: (2022)

A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression
por: Xu, Kequan, et al.
Publicado: (2022)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Publicado: (2023)

LncRNA RP11-422N16.3 Inhibits Cell Proliferation and EMT, and Induces Apoptosis in Hepatocellular Carcinoma Cells by Sponging miR-23b-3p
por: Sun, Yunpeng, et al.
Publicado: (2019)

838. Oral Vancomycin Prophylaxis Works!
por: Van Hise, Nicholas W, et al.
Publicado: (2019)

Super enhancer‐LncRNA SENCR promoted cisplatin resistance and growth of NSCLC through upregulating FLI1
por: Shen, Qiang, et al.
Publicado: (2022)

LncRNA RP11-805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR-34b-3p and miR-139-5p in lung adenocarcinoma
por: Zhu, Huangkai, et al.
Publicado: (2022)

lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC
por: Zheng, Bohao, et al.
Publicado: (2021)

lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC
por: Zheng, Bohao, et al.
Publicado: (2021)

LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer
por: Giro-Perafita, A., et al.
Publicado: (2020)

LncRNA RP11-551L14.4 suppresses breast cancer development by inhibiting the expression of miR-4472
por: Wang, Bin, et al.
Publicado: (2022)

The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma
por: Ying, Tang, et al.
Publicado: (2020)

Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma
por: Huang, Xiaolu, et al.
Publicado: (2022)

m(6)A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1
por: Wu, Yingmin, et al.
Publicado: (2019)

Exosomal miR-1298 and lncRNA-RP11-583F2.2 Expression in Hepato-cellular Carcinoma
por: Matboli, Marwa, et al.
Publicado: (2020)

A novel lncRNA‐miRNA‐mRNA network analysis identified the hub lncRNA RP11‐159F24.1 in the pathogenesis of papillary thyroid cancer
por: Jiang, Wei, et al.
Publicado: (2018)

LncRNA RP11-295G20.2 regulates hepatocellular carcinoma cell growth and autophagy by targeting PTEN to lysosomal degradation
por: Liang, Linhui, et al.
Publicado: (2021)

The implication of lncRNA expression pattern and potential function of lncRNA RP4‐576H24.2 in acute myeloid leukemia
por: Zheng, Jifu, et al.
Publicado: (2019)

lncRNA RP11-10A14.5: a potential prognosis biomarker for LUAD through regulation on proliferation and metastasis
por: Lin, Zhijie, et al.
Publicado: (2022)

LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD
por: Guan, Fulin, et al.
Publicado: (2022)

A new tumor suppressor lncRNA RP11-190D6.2 inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells
por: Tong, Wenxian, et al.
Publicado: (2017)

Experimental Study of lncRNA RP11-815M8.1 Promoting Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells
por: Sun, Xiang, et al.
Publicado: (2021)

LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer
por: Chi, Hong, et al.
Publicado: (2018)

LncRNA RP1-86C11.7 exacerbates the glioma progression and oncogenicity by hsa-miR-144-3p/TFRC signaling.
por: Ma, Qiong, et al.
Publicado: (2021)

Specific expression of lncRNA RP13-650J16.1 and TCONS_00023979 in prostate cancer
por: Zhou, Xiaochen, et al.
Publicado: (2018)

Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer
por: Shi, Debing, et al.
Publicado: (2014)

RP11-552D4.1: a novel m6a-related LncRNA associated with immune status in glioblastoma
por: Zheng, Ping, et al.
Publicado: (2022)

Androgen-Responsive Oncogenic lncRNA RP11-1023L17.1 Enhances c-Myc Protein Stability in Prostate Cancer
por: Huang, Wenhua, et al.
Publicado: (2022)

LncRNA RP11-58O9.2 predicts poor prognosis and promotes progression of non-small cell lung cancer
por: Miao, Xuan, et al.
Publicado: (2023)

LncRNA RP5-998N21.4 promotes immune defense through upregulation of IFIT2 and IFIT3 in schizophrenia
por: Guo, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gemn9sii1ovf5133j2vdum1bou